Medicine recalls
|
| |
| Australia: Recall of Bronchi-cough Pills (qiguanyan kesou tanchuanwan) due to contamination |
| |
The Therapeutic Goods Administration (TGA) advises consumers and health professionals that Beijing Tong Ren Tang Australia is recalling Batch 16080020 and Batch 4080015 of Bronchi-cough Pills (qiguanyan kesou tanchuanwan) due to contamination with substances that pose an unacceptable risk to health.
TGA testing has found that both currently available batches of the product are contaminated with low levels of amygdalin. One batch (16080020) is also contaminated with very low levels of aristolochic acid. Both amygdalin and aristolochic acid are included in Schedule 10 to the Poisons Standard, which lists substances considered to pose an unacceptable risk to health.
There is no established safe exposure level to aristolochic acids, which have been linked to kidney problems and urinary tract cancers. Consumers are advised that if they have Bronchi-cough Pills (qiguanyan kesou tanchuanwan), do not use them.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/bronchi-cough-pills-qiguanyan-kesou-tanchuanwan
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Saturday, Dec 22, 2018
Issued at HKT 12:00
|
| |
